Search Results 101-110 of 8602 for Agmatine Sulfate

  1. Filgotinib In Long-Term Extension Study Of Adults With Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Mirdametinib (oral route) - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule; Tablet for Suspension. Back ...

  3. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  4. (Peak) A Phase 3 Randomized Trial Of CGT9486+Sunitinib Vs. Sunitinib In Subjects With Gastrointestinal Stromal Tumors - Mayo Clinic

    The purpose of this study is to compare CGT9486 in combination with sunitinib to treat gastrointestinal stromal tumors. Participation eligibility. Participant ...

  5. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...

  6. Gemcitabine Hydrochloride In Treating Patients With Locally Advanced Pancreatic Cancer - Mayo Clinic

    This phase I trial studies the side effects and best dose of gemcitabine hydrochloride in treating patients with locally advanced pancreatic cancer. Drugs used ...

  7. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

  8. https://www.mayoclinic.org/chinese_organization_concepts.xml

  9. Arthritis - Doctors and departments - Mayo Clinic

    Learn about how different types of arthritis affect joints in different ways, along with how to get relief from arthritis pain.

  10. A Phase 1b/2 Study Of Onvansertib (PCM-075) In Combination With FOLFIRI And Bevacizumab For Second-Line Treatment Of Metastatic Colorectal Cancer in Patients With A KRAS Mutation - Mayo Clinic

    Participants must have histologically confirmed metastatic and unresectable disease, and previously failed treatment or be intolerant to fluoropyrimidine and ...